Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls
By
The Pink Sheet Daily / Email the Author / “The Pink Sheet” DAILY Oct. 17, 2011
Word Count: 552 / Article # 14111017013
Executive Summary
West Coast contractor Palmetto issues draft proposal establishing a"non-coverage" policy for molecular tests not explicitly covered by Palmetto or a national CMS directive.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.